Works matching IS 17597706 AND DT 2022 AND VI 13 AND IP 14

Results: 11
    1
    2

    Predictive value of post‐treatment C‐reactive protein‐to‐albumin ratio in locally advanced non–small cell lung cancer patients receiving durvalumab after chemoradiotherapy.

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 14, p. 2031, doi. 10.1111/1759-7714.14484
    By:
    • Araki, Taisuke;
    • Tateishi, Kazunari;
    • Komatsu, Masamichi;
    • Sonehara, Kei;
    • Wasamoto, Satoshi;
    • Koyama, Shigeru;
    • Yoshiike, Fumiaki;
    • Hama, Mineyuki;
    • Nishie, Kenichi;
    • Kondo, Daichi;
    • Agatsuma, Toshihiko;
    • Kato, Akane;
    • Takata, Munetake;
    • Kanda, Shintaro;
    • Hanaoka, Masayuki;
    • Koizumi, Tomonobu
    Publication type:
    Article
    3
    4
    5

    Predicting the efficacy of first‐line immunotherapy by combining cancer cachexia and tumor burden in advanced non‐small cell lung cancer.

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 14, p. 2064, doi. 10.1111/1759-7714.14529
    By:
    • Miyawaki, Taichi;
    • Naito, Tateaki;
    • Doshita, Kosei;
    • Kodama, Hiroaki;
    • Mori, Mikiko;
    • Nishioka, Naoya;
    • Iida, Yuko;
    • Miyawaki, Eriko;
    • Mamesaya, Nobuaki;
    • Kobayashi, Haruki;
    • Omori, Shota;
    • Ko, Ryo;
    • Wakuda, Kazushige;
    • Ono, Akira;
    • Kenmotsu, Hirotsugu;
    • Murakami, Haruyasu;
    • Mori, Keita;
    • Harada, Hideyuki;
    • Endo, Masahiro;
    • Takahashi, Kazuhisa
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Issue Information.

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 14, p. 2003, doi. 10.1111/1759-7714.14028
    Publication type:
    Article